EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging (Q44512440)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging (English)

1 reference

Europe PubMed Central

3 December 2017

0 references

inflammatory bowel diseases

0 references

0 references

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

Brian G. Feagan

4

object named as

Brian G Feagan

1 reference

Europe PubMed Central

3 December 2017

author name string

William A Faubion

1

1 reference

Europe PubMed Central

3 December 2017

Joel G Fletcher

2

1 reference

Europe PubMed Central

3 December 2017

Sharon O'Byrne

3

1 reference

Europe PubMed Central

3 December 2017

Willem Js de Villiers

5

1 reference

Europe PubMed Central

3 December 2017

Bruce Salzberg

6

1 reference

Europe PubMed Central

3 December 2017

Scott Plevy

7

1 reference

Europe PubMed Central

3 December 2017

Deborah D Proctor

8

1 reference

Europe PubMed Central

3 December 2017

John F Valentine

9

1 reference

Europe PubMed Central

3 December 2017

Peter D Higgins

10

1 reference

Europe PubMed Central

3 December 2017

Jeffrey M Harris

11

1 reference

Europe PubMed Central

3 December 2017

Lauri Diehl

12

1 reference

Europe PubMed Central

3 December 2017

Lilyan Wright

13

1 reference

Europe PubMed Central

3 December 2017

Gaik Wei Tew

14

1 reference

Europe PubMed Central

3 December 2017

Diana Luca

15

1 reference

Europe PubMed Central

3 December 2017

Karen Basu

16

1 reference

Europe PubMed Central

3 December 2017

Mary E Keir

17

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

15 October 2013

1 reference

Europe PubMed Central

3 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

3 December 2017

108

1 reference

Europe PubMed Central

3 December 2017

12

1 reference

Europe PubMed Central

3 December 2017

1891-1900

1 reference

Europe PubMed Central

3 December 2017

Endoscopic skipping of the distal terminal ileum in Crohn's disease can lead to negative results from ileocolonoscopy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Validation of a lower radiation computed tomography enterography imaging protocol to detect Crohn's disease in the small bowel.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Crohn Disease: mural attenuation and thickness at contrast-enhanced CT Enterography--correlation with endoscopic and histologic findings of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Small bowel involvement in Crohn's disease: a prospective comparison of wireless capsule endoscopy and computed tomography enteroclysis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Computed tomographic enterography adds information to clinical management in small bowel Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

A simple index of Crohn's-disease activity

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Biomarkers in inflammatory bowel disease: current practices and recent advances

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Changes in matrix metalloproteinase (MMP) and tissue inhibitors of metalloproteinases (TIMP) expression profile in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)-2 and -9 in Crohn's disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Skipping Crohn's disease: when ileocolonoscopy is not enough

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.354

21 January 2018

Identifiers

10.1038/AJG.2013.354

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44512440&oldid=2026561031"